Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 117
Filter
1.
Virology ; 435(2): 258-68, 2013 Jan 20.
Article in English | MEDLINE | ID: mdl-23107009

ABSTRACT

The herpesvirus lifestyle results in a long-term interaction between host and invading pathogen, resulting in exquisite adaptation of virus to host. We have sequenced the genomes of nine strains of murine cytomegalovirus (a betaherpesvirus), isolated from free-living mice trapped at locations separated geographically and temporally. Despite this separation these genomes were found to have low levels of nucleotide variation. Of the more than 160 open reading frames, almost 90% had a dN/dS ratio of amino acid substitutions of less than 0.6, indicating the level of purifying selection on the coding potential of MCMV. Examination of selection acting on individual genes at the codon level however indicates some level of positive selection, with 0.03% of codons showing strong evidence for positive selection. Conversely, 1.3% of codons show strong evidence of purifying selection. Alignments of both genome sequences and coding regions suggested that high levels of recombination have shaped the MCMV genome.


Subject(s)
Genome, Viral , Muromegalovirus/genetics , Recombination, Genetic , Selection, Genetic , Amino Acid Sequence , Amino Acid Substitution , Animals , Codon/genetics , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Open Reading Frames , Sequence Analysis, DNA
2.
Epidemiol Infect ; 137(6): 858-70, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18789175

ABSTRACT

Salmonella infections in Antarctic wildlife were first reported in 1970 and in a search for evidence linking isolations with exposure to human activities, a comparison was made of serovars reported from marine fauna in the Antarctic region from 1982-2004 with those from marine mammals in the Northern hemisphere. This revealed that 10 (83%) Salmonella enterica serovars isolated from Antarctic penguins and seals were classifiable in high-frequency (HF) quotients for serovars prevalent in humans and domesticated animals. In Australia, 16 (90%) HF serovars were isolated from marine birds and mammals compared with 12 (86%) HF serovars reported from marine mammals in the Northern hemisphere. In Western Australia, HF serovars from marine species were also recorded in humans, livestock, mussels, effluents and island populations of wildlife in urban coastal areas. Low-frequency S. enterica serovars were rarely detected in humans and not detected in seagulls or marine species. The isolation of S. Enteritidis phage type 4 (PT4), PT8 and PT23 strains from Adélie penguins and a diversity of HF serovars reported from marine fauna in the Antarctic region and coastal areas of Australia, signal the possibility of transient serovars and endemic Salmonella strains recycling back to humans from southern latitudes in marine foodstuffs and feed ingredients.


Subject(s)
Birds , Mammals , Salmonella Infections, Animal/epidemiology , Animals , Animals, Wild , Antarctic Regions/epidemiology , Geography , Human Activities , Humans , Western Australia/epidemiology
3.
J Virol ; 82(13): 6689-96, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18417589

ABSTRACT

Murine cytomegalovirus (MCMV) is widely used to model human cytomegalovirus (HCMV) infection. However, it is known that serially passaged laboratory strains of HCMV differ significantly from recently isolated clinical strains of HCMV. It is therefore axiomatic that clinical models of HCMV using serially passaged strains of MCMV may not be able to fully represent the complexities of the system they are attempting to model and may not fully represent the complex biology of MCMV. To determine whether genotypic and phenotypic differences also exist between laboratory strains of MCMV and wild derived strains of MCMV, we sequenced the genomes of three low-passage strains of MCMV, plus the laboratory strain, K181. We coupled this genetic characterization to their phenotypic characteristics. In contrast to what is seen with HCMV (and rhesus CMV), there were no major genomic rearrangements in the MCMV genomes. In addition, the genome size was remarkably conserved between MCMV strains with no major insertions or deletions. There was, however, significant sequence variation between strains of MCMV, particularly at the genomic termini. These more subtle genetic differences led to considerable differences in in vivo replication with some strains of MCMV, such as WP15B, replicating preferentially in otherwise-MCMV-resistant C57BL/6 mice. CBA mice were no more resistant to MCMV than C57BL/6 mice and for some MCMV strains appeared to control infection less well than C57BL/6 mice. It is apparent that the previously described host resistance patterns of inbred mice and MCMV are not consistently applicable for all MCMV strains.


Subject(s)
Genetic Variation , Genome, Viral/genetics , Muromegalovirus/genetics , Phenotype , Animals , Base Sequence , Mice , Mice, Mutant Strains , Molecular Sequence Data , Sequence Analysis, DNA , Species Specificity
5.
J Reprod Immunol ; 71(2): 102-11, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16870262

ABSTRACT

Species-specific viruses are being genetically engineered to produce contraceptive biological controls for pest animals such as mice, rabbits and foxes. The virus vaccines are intended to trigger an autoimmune response in the target animals that interferes with their fertility in a process termed virally vectored immunocontraception. Laboratory experiments have shown that high levels of infertility can be induced in mice infected with recombinant murine cytomegalovirus and ectromelia virus expressing reproductive antigens as well as in rabbits using myxoma virus vectors. The strategies used to produce and deliver species-specific immunocontraceptive vaccines to free-living wildlife are presented in this review. Discussion includes coverage of the likely safety of the proposed vaccines as well as the implications of the approach for fertility control in other species.


Subject(s)
Contraception, Immunologic/methods , Genetic Vectors , Pest Control, Biological/methods , Viral Vaccines/genetics , Animals , Foxes , Mice , Rabbits , Species Specificity
6.
Epidemiol Infect ; 133(4): 701-10, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16050517

ABSTRACT

To control plagues of free-living mice (Mus domesticus) in Australia, a recombinant murine cytomegalovirus (MCMV) expressing fertility proteins is being developed as an immunocontraceptive agent. Real-time quantitative PCR was used to monitor the transmission of two genetically variable field strains of MCMV through mouse populations after 25% of founding mice were infected with the N1 strain, followed by the G4 strain 6 weeks later. Pathogen-free wild-derived mice were released into outdoor enclosures located in northwestern Victoria (Australia). Of those mice not originally inoculated with virus, N1 DNA was detected in more than 80% of founder mice and a third of their offspring and similarly, G4 DNA was detected in 13% of founder mice and in 3% of their offspring. Thus, prior immunity to N1 did not prevent transmission of G4. This result is promising for successful transmission of an immunocontraceptive vaccine through Australian mouse populations where MCMV infection is endemic.


Subject(s)
Contraception, Immunologic/methods , Herpesviridae Infections/prevention & control , Herpesviridae Infections/transmission , Muromegalovirus/classification , Viral Vaccines/pharmacology , Animals , Animals, Wild , Base Sequence , DNA, Viral/analysis , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Herpesviridae Infections/veterinary , Infection Control , Male , Mice , Molecular Sequence Data , Muromegalovirus/isolation & purification , Probability , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Virus Replication , Western Australia
7.
Vaccine ; 23(23): 2959-69, 2005 Apr 27.
Article in English | MEDLINE | ID: mdl-15811641

ABSTRACT

Cytomegaloviruses are species-specific DNA viruses. Recombinant murine cytomegaloviruse (MCMV) expressing the mouse egg-coat protein zona pellucida 3 (mZP3) has been shown to sterilise female mice by breaking self-tolerance and inducing an immune response against the host ZP3. This virus has the potential to be used for mouse population control, however the effect of this recombinant immunocontraceptive virus in non-host species must be determined. Recombinant MCMV-mZP3, based on both laboratory and wild strains of virus, induced long-lived antibody responses against structural viral proteins and mZP3 when inoculated into laboratory rats, although no viral DNA or replicating virus was identified. The anti-mZP3 antibodies were specific for mouse ZP3, did not cross-react with rat ZP3, and had no effect on the fertility of the rats.


Subject(s)
Contraception, Immunologic , Egg Proteins/immunology , Genetic Vectors , Membrane Glycoproteins/immunology , Muromegalovirus/genetics , Receptors, Cell Surface/immunology , Animals , Antibodies, Viral/blood , Female , Fertility , Mice , Mice, Inbred BALB C , Muromegalovirus/immunology , Rats , Rats, Inbred Lew , Rats, Wistar , Species Specificity , Virus Replication , Zona Pellucida Glycoproteins
8.
J Gen Virol ; 85(Pt 5): 1313-1317, 2004 May.
Article in English | MEDLINE | ID: mdl-15105548

ABSTRACT

Two different betaherpesviruses, the English and Maastricht species of rat cytomegalovirus (CMV), have previously been isolated from Rattus norvegicus. CMVs were isolated from both the brown rat, R. norvegicus, and the black rat, R. rattus, within Australia. The viruses isolated from R. norvegicus appeared to be genetically related to the English species of rat CMV by PCR, RFLP, and sequencing, but the viruses isolated from R. rattus were distinct from both prototype virus species, although more closely genetically related to the Maastricht virus. This is the first genetic characterization of cytomegaloviruses from R. rattus, and the first isolation of CMVs from Australian rats.


Subject(s)
Cytomegalovirus/classification , Muridae/virology , Animals , Australia , Cytomegalovirus/isolation & purification , Cytomegalovirus/physiology , DNA, Viral/analysis , Genes, Viral , Phylogeny , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Rats , Species Specificity
9.
Arch Virol ; 149(3): 447-64, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14991436

ABSTRACT

Inborn resistance to flaviviruses, conferred by a single chromosome 5 locus Flv, is a genetic trait operative in wild mice and a few strains of laboratory mice. In this study we have used in situ hybridisation to trace the spread of flavivirus genomic RNA within the brains of flavivirus susceptible C3H/HeJARC and congenic resistant C3H.PRI- Flv(r) mice following infection with Murray Valley encephalitis virus (MVE) in parallel to studying a brain histopathology and induction of cellular genes involved in antiviral response. We find that in contrast to a high viral RNA content in brains of susceptible mice, viral RNA was markedly reduced in the cortex, olfactory bulb, thalamus and hypothalamus of resistant mice. Trace amounts of viral RNA were detected in the medulla oblongata while it was completely absent from the hippocampus, pons and cerebellum of resistant mice at different time points post infection. The low virus titres within brains of resistant mice coincided with a very mild inflammation, low counts of infiltrating inflammatory cells, and lower IFN I/II and TNFalpha gene induction than in susceptible mice. Furthermore, transcripts of several genes belonging to a 2',5'-oligoadenylate synthetase ( OAS) family, implicated in IFN I-inducible OAS/RNase L antiviral pathway, showed similar brain tissue induction in both strains of mice suggesting only minor contribution of this pathway to the resistance phenotype.


Subject(s)
Brain/immunology , Encephalitis Virus, Murray Valley/physiology , Encephalitis Virus, Murray Valley/pathogenicity , Encephalitis, Arbovirus/immunology , Inflammation/physiopathology , 2',5'-Oligoadenylate Synthetase/genetics , 2',5'-Oligoadenylate Synthetase/metabolism , Acute Disease , Animals , Brain/physiopathology , Brain/virology , Encephalitis, Arbovirus/physiopathology , Encephalitis, Arbovirus/virology , Endoribonucleases/metabolism , Inflammation/immunology , Interferon Type I/metabolism , Mice , Mice, Inbred C3H , RNA, Viral/isolation & purification
10.
J Gen Virol ; 84(Pt 7): 1723-1728, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12810865

ABSTRACT

Enhancement of flavivirus infection in vitro in the presence of subneutralizing concentrations of homologous or heterologous antiserum has been well described. However, the importance of this phenomenon in the enhancement of flavivirus infection in vivo has not been established. In order to study antibody-mediated enhancement of flavivirus infection in vivo, we investigated the effect of passive immunization of mice with Japanese encephalitis virus (JE) antiserum on the outcome of infection with Murray Valley encephalitis virus (MVE). We show that prior treatment of mice with subneutralizing concentrations of heterologous JE antiserum resulted in an increase in viraemia titres and in mortality following challenge with wild-type MVE. Our findings support the hypothesis that subneutralizing concentrations of antibody may enhance flavivirus infection and virulence in vivo. These findings are of potential importance for the design of JE vaccination programs in geographic areas in which MVE co-circulates. Should subneutralizing concentrations of antibody remain in the population following JE vaccination, it is possible that enhanced disease may be observed during MVE epidemics.


Subject(s)
Antibodies, Viral/immunology , Antibody-Dependent Enhancement , Encephalitis Virus, Murray Valley/pathogenicity , Encephalitis, Arbovirus/mortality , Immunization, Passive , Japanese Encephalitis Vaccines/administration & dosage , Animals , Antibodies, Viral/administration & dosage , Antibodies, Viral/blood , Brain/virology , Encephalitis Virus, Japanese/immunology , Encephalitis Virus, Murray Valley/immunology , Encephalitis, Arbovirus/virology , Encephalitis, Japanese/prevention & control , Japanese Encephalitis Vaccines/immunology , Mice , Mice, Inbred BALB C , Vaccination , Viremia/mortality , Viremia/virology , Virulence , Virus Replication
12.
Cell Immunol ; 213(1): 52-61, 2001 Oct 10.
Article in English | MEDLINE | ID: mdl-11747356

ABSTRACT

Murine cytomegalovirus (MCMV) infection of BALB/c mice produces acute and chronic myocarditis similar to clinical disease in humans. In contrast, MCMV-infected C57BL/6 mice develop only mild acute myocarditis. We have investigated the effect of administration of the immunomodulator lipopolysaccharide (LPS) on the development of postviral myocarditis in mice. LPS exacerbated heart inflammation in both strains of MCMV-infected mice, with normally resistant C57BL/6 mice developing chronic myocarditis. Autoantibodies to cardiac myosin were enhanced with LPS treatment in both MCMV-infected mouse strains. LPS treatment also increased the production of TNF in the sera without affecting virus titers in the spleen, liver, or salivary glands, a target organ most affected during persistent virus infection. In LPS/MCMV-infected BALB/c mice, TNF, IL-6, and IL-10 levels were detected in cultures of heart infiltrating cells but not in splenocytes. Importantly, administration of the bioactive synthetic TNF peptide (amino acids 114-130) increased myocarditis in C57BL/6 mice, similar to that seen with LPS treatment. TNF peptide/MCMV-infected BALB/c and C57BL/6 mice showed distinct differences in the expression pattern of IFN-gamma, IL-10, and TNF. These data show that the disease may be partly regulated by TNF among other select cytokines and autoantibodies to cardiac myosin. The immunopathological nature of MCMV-induced myocarditis is thus highlighted.


Subject(s)
Herpesviridae Infections/immunology , Lipopolysaccharides/immunology , Muromegalovirus/immunology , Myocarditis/immunology , Tumor Necrosis Factor-alpha/immunology , Animals , Autoantibodies/blood , Cardiac Myosins/immunology , Cells, Cultured , Cytokines/biosynthesis , Herpesviridae Infections/blood , Herpesviridae Infections/virology , Interleukin-10/biosynthesis , Interleukin-6/biosynthesis , Lipopolysaccharides/administration & dosage , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Muromegalovirus/drug effects , Muromegalovirus/physiology , Myocarditis/blood , Myocarditis/virology , Myocardium/cytology , Peptides/immunology , Peptides/pharmacology , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/pharmacology , Virus Replication/drug effects
13.
J Autoimmun ; 16(3): 175-86, 2001 May.
Article in English | MEDLINE | ID: mdl-11334481

ABSTRACT

We have investigated two models of virally-induced autoimmune myocarditis in mice using widely different infectious agents. Infection of susceptible BALB/c mice with either Coxsackievirus or murine cytomegalovirus results in the development of acute myocarditis from day 7-14 after infection, and chronic myocarditis from day 28 onwards. The chronic phase of myocarditis is associated with mononuclear infiltration of the myocardium and the production of autoantibodies to cardiac myosin, although infectious virus cannot be detected past day 14 of infection. T cells and autoantibodies have been shown to be important for the development of autoimmune myocarditis. Many researchers have investigated the role of molecular mimicry in the development of myocarditis after viral infection. This review explores the 'adjuvant' effect of infection on the innate immune response and how this determines the progression to autoimmune disease. We show that NK cells protect against the development of disease, while complement and complement receptors are involved in the development of autoimmune myocarditis induced by inoculation with virus or cardiac myosin, respectively. Our results suggest that the innate immune response to viral and self-antigens may determine whether susceptible strains of mice progress to chronic autoimmune disease. These findings have broad implications for understanding the role of infection in inducing autoimmune disease.


Subject(s)
Autoimmune Diseases/immunology , Coxsackievirus Infections/immunology , Herpesviridae Infections/immunology , Muromegalovirus/immunology , Myocarditis/immunology , Animals , Autoimmune Diseases/pathology , Autoimmune Diseases/virology , Autoimmunity/immunology , Complement System Proteins/immunology , Coxsackievirus Infections/pathology , Cytokines/immunology , Humans , Immunity, Active/immunology , Immunity, Innate/immunology , Killer Cells, Natural/immunology , Mice , Myocarditis/pathology , Myocarditis/virology
14.
Antimicrob Agents Chemother ; 45(5): 1444-9, 2001 May.
Article in English | MEDLINE | ID: mdl-11302808

ABSTRACT

The cardiovascular disease myocarditis is characterized by inflammation and necrosis of cardiac muscle. This disease has been associated with various viral etiologies, including cytomegalovirus (CMV). Murine CMV (MCMV) infection of adult BALB/c mice produces a disease with acute and chronic phases similar to that found in humans. In our murine model, we have investigated the therapeutic efficacy of antiviral drug administration on myocarditis. Two drugs commonly used for CMV treatment, ganciclovir and cidofovir, were subjected to trials, with both drugs showing potent antiviral activity against MCMV both in vitro and in vivo. The acute phase of myocarditis was significantly reduced when antiviral therapy commenced 24 h postinfection. Such treatment also reduced the severity of the chronic phase of myocarditis. In contrast, antiviral treatment commencing after the acute phase had no effect on chronic myocarditis. Reinfection of mice with MCMV caused exacerbation of myocardial inflammation. Such an increase in severity of myocarditis could be prevented with either ganciclovir or cidofovir treatment, but the preexisting inflammation and necrosis of the myocardium persisted. These data highlight possible therapeutic uses of antiviral drugs in viral myocarditis as well as further elucidating the pathogenic nature of the disease.


Subject(s)
Antiviral Agents/therapeutic use , Cytosine/therapeutic use , Ganciclovir/therapeutic use , Herpesviridae Infections/drug therapy , Myocarditis/drug therapy , Organophosphonates , Organophosphorus Compounds/therapeutic use , Animals , Cidofovir , Cytosine/analogs & derivatives , Disease Models, Animal , Male , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Muromegalovirus/drug effects , Myocarditis/virology
15.
J Immunol ; 166(3): 1796-802, 2001 Feb 01.
Article in English | MEDLINE | ID: mdl-11160226

ABSTRACT

NK cells mediate early host defense against viral infection. In murine CMV (MCMV) infection NK cells play a critical role in controlling viral replication in target organs, such as spleen and liver. Until now it has not been possible to directly examine the role of NK cells in MCMV-induced inflammation in situ due to the inability to stain specifically for NK cells in infected tissues. In this study, we describe a method of in vivo fixation, resulting in the first identification of NK cells in situ using NK1.1 as the marker. Using this method, we characterize the NK1.1(+) cellular component of the inflammatory response to wild-type MCMV in the spleen, liver, and lung of genetically susceptible and resistant mice following i.p. infection. This study provides the first in situ description of the cellular response mediated specifically by NK cells following MCMV infection.


Subject(s)
Antigens/biosynthesis , Herpesviridae Infections/immunology , Killer Cells, Natural/immunology , Killer Cells, Natural/virology , Muromegalovirus/immunology , Protein Biosynthesis , Animals , Antigens/analysis , Antigens, Ly , Antigens, Surface , Biomarkers/analysis , Fluorescent Antibody Technique, Indirect , Herpesviridae Infections/metabolism , Herpesviridae Infections/pathology , Killer Cells, Natural/chemistry , Lectins, C-Type , Liver/chemistry , Liver/immunology , Liver/pathology , Liver/virology , Lung/chemistry , Lung/immunology , Lung/pathology , Lung/virology , Mice , Mice, Congenic , Mice, Inbred BALB C , Mice, Inbred C57BL , NK Cell Lectin-Like Receptor Subfamily B , Proteins/analysis , Spleen/chemistry , Spleen/immunology , Spleen/pathology , Spleen/virology , Viral Plaque Assay
16.
J Wildl Dis ; 35(2): 301-10, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10231757

ABSTRACT

House mice (Mus domesticus) were recently introduced to Thevenard Island, off the northwest coast of Western Australia. This island is also habitat for an endangered native rodent, the short-tailed mouse (Leggadina lakedownensis). Concerns have been raised that house mice may pose a threat to L. lakedownensis both through competition and as a source of infection. To assess the threat to L. lakedownensis posed by viral pathogens from M. domesticus, a serological survey was conducted from 1994 to 1996 of both species for evidence of infection with 14 common murine viruses (mouse hepatitis virus, murine cytomegalovirus, lymphocytic choriomeningitis virus, ectromelia virus, mouse adenovirus strains FL and K87, minute virus of mice, mouse parvovirus, reovirus type 3, Sendai virus, Theiler's mouse encephalomyelitis virus, polyoma virus, pneumonia virus of mice, and encephalomyocarditis virus) and Mycoplasma pulmonis. Despite previous evidence that populations of free-living M. domesticus from various locations on the Australian mainland were infected with up to eight viruses, M. domesticus on Thevenard Island were seropositive only to murine cytomegalovirus (MCMV). Antibodies to MCMV were detected in this species at all times of sampling, although seroprevalence varied. Infectious MCMV could be isolated in culture of salivary gland homogenates from seropositive mice. In contrast, L. lakedownensis on Thevenard Island showed no serological evidence of infection with MCMV, any of the other murine viruses, or M. Pulmonis, and no virus could be isolated in culture from salivary gland homogenates. Although MCMV replicated to high titers in experimentally infected inbred BALB/c laboratory mice as expected, it did not replicate in the target organs of experimentally inoculated L. lakedownensis, indicating that the strict host specificity of MCMV may prevent its infection of L. lakedownensis. These results suggest that native mice on Thevenard Island are not at risk of MCMV infection from introduced house mice, and raise interesting questions about the possible selective survival of MCMV in small isolated populations of M. domesticus.


Subject(s)
Mice , Muridae , Rodent Diseases/epidemiology , Virus Diseases/veterinary , Animals , Animals, Wild , Antibodies, Viral/blood , Female , Herpesviridae Infections/epidemiology , Herpesviridae Infections/immunology , Herpesviridae Infections/veterinary , Mice, Inbred BALB C , Muromegalovirus/immunology , Muromegalovirus/isolation & purification , Muromegalovirus/physiology , Population Dynamics , Specific Pathogen-Free Organisms , Virus Diseases/epidemiology , Virus Replication , Western Australia/epidemiology
17.
J Gen Virol ; 80 ( Pt 4): 897-906, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10211958

ABSTRACT

A single genetic locus, flavivirus resistance (Flv), controls virus titres and severity of flavivirus infection in mouse brain. It has been mapped to mouse chromosome 5 and shown to include different allelic forms. While the majority of laboratory mouse strains are susceptible to flaviviruses and carry the Flv(s) allele, wild mice and laboratory mouse strains recently derived from them are resistant and carry flavivirus-resistance alleles including Flv(r)-like and Flv(mr) alleles. Although there is a mouse model of flavivirus resistance conferred by the Flv(r) allele, other resistance alleles have not been adequately studied due to a lack of appropriate animal models. In this paper we describe the development of new flavivirus-resistant mouse strains, C3H.M.domesticus-Flv(r) and C3H.MOLD-Flv(mr), which carry the novel resistance alleles Flv(r)-like and Flv(mr) on the genetic background of flavivirus susceptible C3H/HeJ mice. The new strains were created by 10 to 11 generations of backcrossing followed by brother-sister matings resulting in a generation of homozygous founder stocks. Genome analysis of the newly developed mouse strains has revealed chromosomal regions of approximately 9 and 11 cM, respectively, encompassing Flv on chromosome 5, which are derived from resistant donor mice. These segments are much smaller than the segment of approximately 31 cM described in the congenic resistant mouse strain C3H.PRI-Flv(r) (also known as C3H/RV). The new congenic mouse strains, which were created to carry the Flv(r)-like and Flv(mr) alleles on the standardized genetic background of susceptible mice, represent new animal models of flavivirus resistance conferred by these novel resistance alleles.


Subject(s)
Alleles , Chromosome Mapping , Flavivirus Infections/genetics , Animals , Genetic Predisposition to Disease , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Polymorphism, Genetic , Species Specificity , Virus Replication
18.
Immunology ; 94(2): 263-70, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9741351

ABSTRACT

The laboratory-adapted K181 strain of murine cytomegalovirus (MCMV) induces both acute and chronic myocarditis, associated with autoantibodies to cardiac myosin, in susceptible BALB/c mice. However, the K181 MCMV strain has been maintained in the laboratory for many years and may not resemble naturally occurring strains of MCMV in its ability to induce myocarditis. Accordingly, six different isolates of MCMV from wild Mus domesticus were compared with K181 MCMV for their ability to induce myocarditis and autoantibodies to cardiac myosin in BALB/c mice. These isolates were shown to induce acute myocarditis similar to K181 MCMV, with associated focal and diffuse myocardial inflammation. However, the levels of myocarditis induced by the wild isolates during the chronic phase of the disease (days 32-56 post-infection) were low in contrast to the K181 strain. Interestingly, 30% of wild-trapped mice showed histological evidence of myocarditis and all were sero-positive to MCMV. Sera from BALB/c mice infected with wild MCMV isolates and from wild-trapped mice contained antibodies that cross-reacted with MCMV and cardiac myosin (S2 region). The cross-reactive region of MCMV was found to be a 50,000-55,000 MW viral polypeptide. These findings suggest that molecular mimicry may be involved in the pathogenesis of autoimmune myocarditis following infection with both laboratory and wild MCMV strains.


Subject(s)
Antibodies, Viral/biosynthesis , Autoantibodies/biosynthesis , Autoimmune Diseases/virology , Cytomegalovirus Infections/immunology , Myocarditis/virology , Acute Disease , Animals , Autoimmune Diseases/immunology , Cross Reactions , Female , Immunoblotting , Mice , Mice, Inbred BALB C , Molecular Mimicry , Muromegalovirus/immunology , Myocarditis/immunology , Myocardium/immunology , Myosins/immunology , Species Specificity
19.
Arch Virol ; 143(4): 697-715, 1998.
Article in English | MEDLINE | ID: mdl-9638142

ABSTRACT

Inherited resistance to flaviviruses in laboratory mice is a rare trait conferred by an autosomal dominant gene (Flvr). To provide information on genetic resistance to flaviviruses in wild mice, we analysed (i) wild M. m. domesticus trapped in Australia, and (ii) mice representing other species and subspecies in the genus Mus. Mice were screened for resistance relative to C3H/HeJ mice by intracerebral challenge with Murray Valley encephalitis virus or yellow fever virus, and breeding studies were undertaken to identify inherited resistance factors. Widespread flavivirus resistance was demonstrated in Australian M. m. domesticus. A single, autosomal dominant Flvr-like gene appeared to be primarily responsible, but there was some evidence for additional inherited resistance factors. Flavivirus resistance was also identified in other taxonomic groups, and a genetic basis for this resistance was demonstrated in M. m. musculus (Skive), M. spretus, and M. spicilegus. Interestingly, M. m. musculus (CZI-O) were more susceptible than C3H/HeJ mice. Our findings show that genetic resistance to flaviviruses is common in divergent taxonomic groups in the genus Mus, suggesting that the trait has an ancient evolutionary origin, but whether flavivirus resistance genes have an anti-viral role or serve some other function is unknown.


Subject(s)
Encephalitis Virus, Murray Valley , Encephalitis, Arbovirus/veterinary , Muridae , Yellow Fever/veterinary , Animals , Animals, Wild , Australia , Crosses, Genetic , Encephalitis, Arbovirus/genetics , Encephalitis, Arbovirus/immunology , Female , Immunity, Innate/genetics , Male , Mice , Mice, Inbred C3H , Species Specificity , Virus Replication , Yellow Fever/genetics , Yellow Fever/immunology
20.
Rev Sci Tech ; 17(1): 231-48, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9638813

ABSTRACT

Flaviviruses are small, enveloped RNA viruses which are generally transmitted by arthropods to animals and man. Although flaviviruses cause important diseases in domestic animals and man, flaviviral infection of animals which constitute the normal vertebrate reservoir may be mild or sub-clinical, which suggests that some adaptation between virus and host may have occurred. While this possibility is difficult to study in wild animals, extensive studies using laboratory mice have demonstrated the existence of innate, flavivirus-specific resistance. Resistance is heritable and is attributable to the gene Flvr, which is located on chromosome 5 in this species. The mechanism of resistance is at present unknown, but acts early and limits the replication of flaviviruses in cells. While some evidence supports a role for Flvr in enhancing the production of defective interfering virus, thereby restricting the production of infectious virus, other reports suggest that Flvr interferes with either virus RNA replication or RNA packaging. Recent research suggests that cytoplasmic proteins bind to the viral replication complex and that allelic forms of these proteins in resistant mice may restrict the production of infectious progeny. Apparent resistance to flaviviruses has been described in other vertebrates, although it remains to be seen if this is attributable to a homologue of Flvr. Nonetheless, knowledge gained of the characteristics and function of Flvr in mice should be applicable to other host species, and improvement of resistance to flaviviral infection in domestic animals by selective breeding or gene technology may ultimately be possible.


Subject(s)
Animals, Domestic , Animals, Wild , Arthropod Vectors/virology , Flavivirus Infections/veterinary , Flavivirus/physiology , Animals , Flavivirus Infections/genetics , Flavivirus Infections/immunology , Humans , Immunity, Innate/genetics , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...